Social Risks-Focused Lifestyle Intervention to Reduce Preeclampsia (SAIL)
SAIL
2 other identifiers
interventional
100
1 country
1
Brief Summary
Preeclampsia is a disease of pregnancy and first few weeks after birth. It is diagnosed as new onset of high blood pressure and injury to organs such as kidneys, liver, and brain. Preeclampsia is growing at a rapid rate - rate that exceeds diabetes and heart disease. Over half a million lives lost each year to preeclampsia. Women with a history of preeclampsia have 3-4 times the risk of high blood pressure. They also have double the risk for heart disease and stroke. Racial and ethnic disparities are present in preeclampsia. Black women are at higher risk of developing preeclampsia. They are also at much higher risk of dying from preeclampsia than other women. The reasons behind such disparities are unclear. What may explain these differences are social determinants of health. The contribution of social determinants to differences in preeclampsia is well recognized. However, a major gap in research remains strategies that address these factors. Our study will test a lifestyle intervention incorporating social risk factors to reduce the risk of preeclampsia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2021
CompletedFirst Posted
Study publicly available on registry
July 12, 2021
CompletedStudy Start
First participant enrolled
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 7, 2025
August 1, 2025
2.7 years
June 28, 2021
August 3, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Retention
Retention will be measured by session attendance rates.
Post intervention measured at the completion of the last study visit, 3 years
Systolic and diastolic blood pressure: Post Intervention
BP will be taken by a study trained and certified research assistant using the study OMRON automated device.
Post intervention/at the last study visit, up to 40 weeks
Systolic and diastolic blood pressure: 6 Weeks Postpartum
BP will be taken by a study trained and certified research assistant using the study OMRON automated device.
At 6 weeks postpartum visit
Secondary Outcomes (1)
Preeclampsia
At the 6 weeks postpartum visit through patient interview, confirmed with medical record review
Study Arms (2)
Routine prenatal care
NO INTERVENTIONRoutine prenatal care: All women participating in the study will receive routine prenatal care by their obstetric provider, consisting of 1 prenatal visit a month up to 28 weeks of gestation, 1 prenatal visit every 2 weeks during 28-36 weeks and weekly visits during 36-40 weeks.
SAIL intervention
EXPERIMENTAL6 monthly group sessions with the study nurse with a background in prenatal care and the PI that will include each group will include preeclampsia education, coaching on stress management, resource navigation, and training in problem solving.
Interventions
6 monthly group sessions with the study nurse with a background in prenatal care and the PI that will include each group will include preeclampsia education, coaching on stress management, resource navigation, and training in problem solving.
Eligibility Criteria
You may qualify if:
- self-report as African-American/Non-Hispanic black
- residence in inner-city Milwaukee
- nulliparity
- gestational age at enrollment \<=16 weeks
- able and willing to give informed consent
You may not qualify if:
- not able to communicate in English
- major fetal anomaly
- psychiatric illness that precludes group participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical College of Wisconsinlead
- American Heart Associationcollaborator
Study Sites (1)
Medical College of Wisconsin
Wauwatosa, Wisconsin, 53226, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 28, 2021
First Posted
July 12, 2021
Study Start
March 28, 2022
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
August 7, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
The proposed study will be conducted, and the data analyzed, and results disseminated in an objective and transparent manner. All investigators are aware of and agree to abide by the principles for sharing research resources, as described by NIH in "Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Programs."